Small Molecules Pushing Erythroid/Megakaryocyte Cell Specification Boundaries
A combination of a MEK/ERK-signaling inhibitor and three chromatin-remodeling molecules enhances generation of platelet-producing megakaryocytes in vitro, possibly through direct reprogramming.